Retevmo Interactions
There are 631 drugs known to interact with Retevmo (selpercatinib), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 290 are major, 317 are moderate, and 24 are minor.
- View all 631 medications that may interact with Retevmo
- View Retevmo alcohol/food interactions (2)
- View Retevmo disease interactions (7)
Most frequently checked interactions
View interaction reports for Retevmo (selpercatinib) and the medicines listed below.
- acetaminophen / butalbital / caffeine
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- albuterol
- Alcohol (contained in alcoholic beverages) (ethanol)
- Align (bifidobacterium infantis)
- Allegra Allergy (fexofenadine)
- amlodipine
- atenolol
- Ativan (lorazepam)
- atorvastatin
- calcium / vitamin d
- Dramamine (dimenhydrinate)
- gabapentin
- hydrochlorothiazide
- ibuprofen
- levothyroxine
- liothyronine
- lorazepam
- losartan
- melatonin
- meloxicam
- omeprazole
- oxycodone
- potassium chloride
- Synthroid (levothyroxine)
- tramadol
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Retevmo alcohol/food interactions
There are 2 alcohol/food interactions with Retevmo (selpercatinib).
Retevmo disease interactions
There are 7 disease interactions with Retevmo (selpercatinib) which include:
- bleeding
- hypertension
- ILD/pneumonitis
- liver dysfunction
- tumor lysis syndrome
- Selpercatinib – arrhythmias
- Selpercatinib – renal dysfunction
Report options
More about Retevmo (selpercatinib)
- Retevmo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Armour Thyroid
Armour Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid ...
NP Thyroid
NP Thyroid is used for hashimoto's disease, hypothyroidism, after thyroid removal, thyroid cancer ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Dabrafenib
Dabrafenib is used for low-grade glioma, melanoma, metastatic, non small cell lung cancer, solid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
